Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Genética | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
INTERVENTIONAL
Inicio: 24 de oct de 2022
ID: NCT05253651
Reclutando
RENIS
Estudios farmacogeneticos en leucemias y linfomas
OBSERVATIONAL
ID: IS001393
Reclutando
RENIS
ESTUDIO DE LA INFECCIÓN POR EL VIRUS DE LA HEPATITIS B EN DONANTES DE SANGRE LA PROVINCIA DE MISIONES: PREVALENCIA, COINFECCIONES, INFECCIÓN OCULTA Y VARIABILIDAD GENOMICA.
OBSERVATIONAL
ID: IS000307
Desconocido
ClinicalTrials.gov
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections
OBSERVATIONAL
Inicio: 1 de jul de 2005
ID: NCT00657969
Reclutando
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
INTERVENTIONAL
Inicio: 16 de feb de 2026
ID: NCT07220083
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
INTERVENTIONAL
Inicio: 20 de sept de 2012
ID: NCT01686633
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Global, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
INTERVENTIONAL
Inicio: 11 de dic de 2019
ID: NCT04136184
Completado
Fase 3
ClinicalTrials.gov
A Study of the Efficacy and Safety of Multiple Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia
INTERVENTIONAL
Inicio: 28 de oct de 2010
ID: NCT01231607
Activo, no recluta
ClinicalTrials.gov
Prospective Clinical Assessment Study in Children With Achondroplasia: The PROPEL Trial
OBSERVATIONAL
Inicio: 12 de ago de 2019
ID: NCT04035811
Activo, no recluta
Fase 3
ClinicalTrials.gov
MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)
INTERVENTIONAL
Inicio: 22 de nov de 2024
ID: NCT06672237
Completado
ClinicalTrials.gov
A Case-Control Toxicogenomics Study to Identify Unique Genetic Polymorphisms in Patients Who Have Experienced Symptomatic Hepatotoxicity or Severe Cutaneous Toxicity Within the First 8 Weeks of Nevirapine Therapy
OBSERVATIONAL
Inicio: 1 de feb de 2006
ID: NCT00310843
Reclutando
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial Of Valemetostat Tosylate Plus Pembrolizumab Vs Pembrolizumab Alone in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Tumor Proportion Score ≥50% Without Actionable Genomic Alterations
INTERVENTIONAL
Inicio: 30 de oct de 2024
ID: NCT06644768
Por invitación
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
INTERVENTIONAL
Inicio: 3 de dic de 2024
ID: NCT06679946
Desconocido
Fase 3
ClinicalTrials.gov
Treatment of Nasal Staphylococcus Aureus Colonization in Patients With Hereditary Hemorrhagic Telangiectasia With Recurrent Epistaxis.
INTERVENTIONAL
Inicio: 1 de jun de 2017
ID: NCT02963129
Completado
Fase 3
ClinicalTrials.gov
Open Label, Multicenter Study to Evaluate Safety, Local Tolerability, Convenience, and Efficacy of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
INTERVENTIONAL
Inicio: 25 de sept de 2009
ID: NCT00997204
Completado
ClinicalTrials.gov
F2-PROTOCOL: Prospective Collection of Data of Possible Prognostic Relevance in Patients With Follicular Lymphoma
OBSERVATIONAL
Inicio: 1 de feb de 2003
ID: NCT01250223
Terminado
ClinicalTrials.gov
Natural History Study of Children With Metachromatic Leukodystrophy
OBSERVATIONAL
Inicio: 2 de nov de 2015
ID: NCT01963650
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01760005
Terminado
Fase 3
ClinicalTrials.gov
A Phase 2/3, Multicenter, Double-Blind, Randomized, Controlled Study Of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) In Closed Diaphyseal Tibial Fracture
INTERVENTIONAL
Inicio: 1 de nov de 2006
ID: NCT00387686
Terminado
ClinicalTrials.gov
International Multi-center, Randomized and Controlled Clinical Study, to Evaluate the Clinical Benefit of the ERA Test in Infertile Patients Undergoing Assisted Reproduction Treatment and Medical Indication of PGT-A.
INTERVENTIONAL
Inicio: 28 de may de 2018
ID: NCT03530254
1
2
...
434
Siguiente
Filtros